← Back to Discover

Royalty Pharma Sub-Manager, LLC

Period ended Sep 30, 2026 · Latest filing Nov 13, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $196,268,588

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. CYTOKINETICS, INC · COM · 23282W605 · shares: $64,617,637
  2. ZENAS BIOPHARMA, INC. · COM · 98937L105 · shares: $64,408,406
  3. BIOHAVEN LTD · COM · G1110E107 · shares: $39,202,368
  4. KAILERA THERAPEUTICS · COM · 482931102 · shares: $28,040,177

Reported holdings

4 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
CYTOKINETICS, INCCOM23282W605 — 980,392 shares $64,617,637
ZENAS BIOPHARMA, INC.COM98937L105 — 2,388,150 shares $64,408,406
BIOHAVEN LTDCOMG1110E107 — 2,936,507 shares $39,202,368
KAILERA THERAPEUTICSCOM482931102 — 2,455,357 shares $28,040,177